chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is an instance of breakthrough COVID-19 disease after which death occurred.  The individual was vaccinated with the Pfizer product on 01/30/2021, 02/20/2021, and 10/07/2021. I only have dates administered for the first 2 doses, no other information was entered.   The individual first tested positive for COVID-19 on 01/24/2022 at the nursing home at which they were a resident. The individual presented to Emergency Department on 01/30/2022 with symptoms of shortness of breath and hypoxia. They were admitted to hospital same day and tested positive for COVID-19 again on 01/31/2022. The individual suffered an instance of liquid aspiration while drinking a beverage on 02/13/2022 and this lead to respiratory failure and intubation. They ultimately suffered a cardiac arrest and died later on the same day of 02/13/2022.
Pt recvd 1st dose of Engerix-B vax on 1JUL91 & 2nd dose 8AUG91 for Hep B prevention; 2 hrs p/2nd dose, pt exp h/a, then aching & fatigue; no fever; given APAP;
A type IV reaction is described as redness, swelling and pain from injection site down the left arm. Lasted 2 days. No treatment.
CLL condition exacerbated with rapid health decline. Patient misdiagnosed after vaccines for B-cell marginal lymphoma with iron infusion and then regular bi-weekly blood transfusions. Patient was very anemic and seemed as if he was dying of amyloidosis (most of the symptoms). Rapid decline in health. After a few months of testing (bone biopsy, skin biopsy, blood panels, etc.), a proper diagnosis at local medical center was given: lymphoplasmacytic lymphoma with a MYD88 mutation. The diagnosis is so rare (less than 2% of reported lymphoma) that patient was misdiagnosed previously, which one could argue partly contributed to decline. Symptoms occurred within weeks of receiving vaccine #2 on 03/04/21. Average reported flu like symptoms after injection(s). Unknown if vaccine caused this condition for the CLL to become exacerbated. Previous to 2nd vaccine, patient was stable without the need for iron or blood transfusions or treatment of MYD88 mutation.
1. Chronic spontaneous urticaria -12 days after booster.  Itching, hives, red marks etc all over body besides breasts. Went to ER 5-6 days later and received loratadine (10mg) 1x a day for 10 days, MethtylPrednisolone (4mg) 21 tablets over the course of 6 days Famotidine (20mg) 2x a day for 5 days Hydrocortisone (tube for application)  IV during ER visit of steroids which reduced redness and rash.  Meds reduced rash significantly but once meds were finished rash and itchiness has returned.  2. Vasovagonsyncope the morning after booster, 10 minutes after waking. Woke up in middle of the night and trouble sleeping prior to incident. 3. Swollen lymph nodes and painful armpit. Was resolved 5 days post vaccine by receiving a lymphatic drainage massage.
Received phone call from school nurse. Child developed rash near nose after vaccine was given.  On next day rash was on side of face. He was in no distress and was at school.
Tdap 0.5 ML was inadvertently administered instead of Hep A. CDC was contacted, parents, and dept head and supervisor was notified. Adverse reactions and potential side effects were discussed. Proper medication Hep A 0.5 and was administered    to patient
initially had bilateral ear swelling, itching, redness, then face and neck rash appeared.  Sx first appeared 5-6 days after vaccine, progressed over following 5 days to involve face and neck.  No other systemic symptoms such as shortness of breath, difficulty swallowing,  significant nausea, vomiting, dizziness
Severe local allergic in which there was around 7x8 inch area of erythema/swelling along with several raised bullae/ vesicles up to 1 inch in diameter.
Patient described oral temperature of 100.4 degrees Fahrenheit, fatigue, joint and muscle pain, chills, headache, neck stiffness and pain, cough, nausea and vomiting.  Declined medical treatment when it was suggested to her.  On 1/18/23, she reported still having a cough and fatigue.
After the vaccination from my head to the leg I had burning pain and it got severe during the daytime. The doctor told me to go to the Neurologist and I have an appointment in February. My primary doctor gave me a couple of pain medications.
sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Other HCP). The reporter is the patient. Other Case identifier(s): MDCA22-00239 (Moderna).  An adult female patient received bnt162b2 (BNT162B2), administration date 16Jul2021 (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 17Jul2021, outcome "unknown", described as "sore arm".  Additional Information: Patient had the Moderna Booster Dose (Lot No.063H21A) on 16Jan2022. Patient was fine on 17Jan2022, but on 19Jan2022 she woke up feeling like she was thrown down a set of stairs. The patient didn't know the timeline of the side effects of the Moderna booster. She wanted to know how long it's supposed to last for. She was feeling like crap. Head was pounding, body feels like Hiten by a truck, elbows and joints were so sore. She had trouble lifting stuff; it was painful on the crease inside her elbows (the muscles and joints). She was struggling to bend over. She was feeling chilly. She felt stiff in morning on 19Jan2022, but it worsened throughout the course of the day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rash and swelling started about 1 1/2 hours after vaccine at vaccine site (Right thigh), redness, swelling spread to upper thigh. Redness did get better but then worse again on 7th day. Child was started on steroids. No fever.
ADMINISTERED PAST THE CURRENT REFRIGERATION BEYOND THE CURRENT USE DATE AS LISTED IN EUA
Extreme headaches that lasted for 4 weeks.  Extreme nausea that lasted 1 week.  Chest pain many times during the first 4 week's
8 days after shot, dime sized bruising appeared at injection site,  along with a red circle about two inches in diameter. Was not raised, painful, or sensitive. Went away with no treatment after about 2 days.
Information has been received from a lawyer regarding a case in litigation concerning a female of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2010, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Very shortly after getting flu shot on 10/17/13; child had (R) abd pain, rhinitis, sore throat. He did not tell teacher but told parents and was taken to ER. In clinic, 10/18/13 after taking 25 mg BENADRYL - subjective improvement by child and parent.
The pt had trouble breathing and chest tightness; The pt had trouble breathing and chest tightness; This spontaneous report was received from a consumer referring to a 60-year-old female patient.      On an unknown date in 2019, the patient was vaccinated for prophylaxis with Pneumococcal Vaccine, Polyvalent (23-valent) (manufacturer unknown) (dosage regimen, route of administration, lot number and expiration date were not provided.         On an unknown date, the patient had trouble breathing and chest tightness. The outcome of the events was not reported. Causality assessment was not provided.  The litigation case refers the patient had claimed suffered herpes zoster due to zoster vaccine live (ZOSTAVAX) (captured on MARRS # 2002USA003324).; Sender's Comments:  US-009507513-2002USA003324:
Hives that turn into welps. This is is happening on hands arm back neck. Knot in throat
My son got  both  moderna shots in april. they now have been told they have the covid virus; Lack of drug effect; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (My son got  both  moderna shots in april. they now have been told they have the covid virus) and DRUG INEFFECTIVE (Lack of drug effect) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (My son got  both  moderna shots in april. they now have been told they have the covid virus) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (My son got  both  moderna shots in april. they now have been told they have the covid virus) and DRUG INEFFECTIVE (Lack of drug effect) outcome was unknown.            Concomitant products were not provided. Treatment medication were not reported.  This is a case of COVID test positive and is unrelated because the vaccine does not contain viruses, although the patient can be infected independently from the vaccination, hence the MAH causality is not applicable.   Reporter did not allow further contact; Sender's Comments: This is a case of COVID test positive and is unrelated because the vaccine does not contain viruses, although the patient can be infected independently from the vaccination, hence the MAH causality is not applicable.
I had stopped getting seizures for a few years after I took the second dose a month or two later they started acting up again. I reached out on social media to other people with a history of seizures and I've gotten a few yes back. I'm very scared
Heart Attack. A feeling of burning in my arms and mouth of the stomach, in addition to fatigue when walking, started on June 12, 2021. I never had such pain before and thought it's just a stomach virus or so. As the pain continues, I called my primary-care Dr. early morning of June 17 and scheduled appointment for a week later. But around 9:30 pm that day, June 17, the pain became so severe, in addition to nausea and shortness of breath. I went to emergency room and have been told that there is acute heart attack in progress and was moved to the Critical Care Unit in the Heart and Vascular Center. A blockage has been removed and a stent was installed in morning of June 18, through heart catheterization procedure. As there was damage to the heart muscle due to the heart attack, I am supposed to go back later, in 4-6 weeks, to remove couple more blockages and install stents.
Routine seasonal flu shot provided on 10/28/2010 1st report back pain shaky 11/8/10 2nd report unsteady gait 11/10/10 to ER at Medical Center 11/10/11 with return to Correctional Institute at 2100 11/11/10 report barely got out of bed, progressive weakness noted 11/11/10 2100 ER medical center R/O Guillain Barre.
2-3 hrs p/vax color became green)ashen); almost went into convuls according to father; afeb, limp episode occurred x 1 for a few mins; also described as droopy, very weak; taken to ER;
Nausea; Sore body/Hurt body; This non-serious case was reported by a other health professional via call center representative and described the occurrence of nausea in a unspecified number of patients who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patients received the 1st dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patients experienced nausea (Verbatim: Nausea) and general body pain (Verbatim: Sore body/Hurt body). The outcome of the nausea and general body pain were unknown.   It was unknown if the reporter considered the nausea and general body pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.     It was unknown if the company considered the nausea and general body pain to be related to Bexsero and Bexsero Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 25-OCT-2023  The reporter reported that less than 5 people (patients) had bad reactions of sore body, hurt body and nausea after the Bexsero. The reporter had no further information about the event. The reporter consented to follow up.
This spontaneous report was received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No pertinent medical history was reported. On an unknown date at unspecified times in January 2015, the patients were vaccinated with PEDVAXHIB 0.5 ml once, intramuscular which was improperly stored. No adverse effect reported. No Product Quality Complaint (PQC) was involved. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown demographics. On unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB (lot # L025738, expiry date: 14-AUG-2017 and lot # M013639, expiry date: 15-NOV-2017). No adverse effects were reported. Excursion information: Time: 30 Minutes, Temperature: 9C and Time: 30 Minutes, Temperature: 11C. The call was because of a data logger. The improperly stored doses were administered. The were no previous excursions. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Seizure, admission to hospital on July 3, 2018. After performing multiple tests, no anomalies were found. Gabapentin 100mg 3 times per day prescribed. I was discharged on July 4, 2018.
My son's cold symptoms started on 12/14/2022 in the morning around 8:00AM. He had cough, congestion, and headache. He progressed to complain about ear ache and headache. On 12/16/2022 he woke in the morning with complaining of his eyes and he had a pink eye. On the same day we took him to the doctors office they diagnosed him with Adeno Virus. We gave him over the counter eye drops for 7 days. We did home test for COVID-19 which was negative. On 12/26/2022 we did a PCR for COVID-19 and the results came back on the 12/28/2022 which was negative.
I received the vaccine late afternoon on 4/8 around 5:30 pm.  The next morning 4/9 about 8:30 am I had a slight fever of 100.5, my shoulder at the sight of the injection was swollen, I had a few chills, and felt fatigued.  Later in the afternoon probably about 4:00, the fever spiked to 101.2.  During the day my hands got so cold I had to use hand warmers and wear gloves.   I was able to work until 2:00 pm but then laid down in bed to rest.  The next morning 4/10 I felt fine.   Overall, I was not seriously ill but just wanted to report these symptoms.  I had no symptoms after my first dose.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Oct2022 as dose 5 (booster), single (Lot number: GH9703) at the age of 69 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 26Mar2022 as dose 4 (booster), single (Lot number: FJ6369), in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Lot number: EN6202), in right arm, on 17Mar2021 as dose 2, single (Lot number: EP6955), in right arm and on 23Aug2021 as dose 3 (booster), single (Lot number: FC3183), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Autoimmune diseases" (unspecified if ongoing); "celiac" (unspecified if ongoing); "rheumatiod arthritis" (unspecified if ongoing); "lupus SLE" (unspecified if ongoing); "microscopic Lymphocytic colitis" (unspecified if ongoing); "degenerative disc disease in neck" (unspecified if ongoing); "known allergies Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient received PAXLOVID as treatment for Covid-19 from 15Dec2022 to 20Dec2022.
MODERNA COVID VACCINE #3 GIVEN 11/09/2021, LOT #076C21A; Pt passed away in facility, Center for Rehab; COD is COVID 19; pt also had a hospital admission prior to going to facility, for hypernatremia, dehydration and kidney disease
Pt 055 in clinical study MPL318-01 with a history of hemorrhoids had a preplanned hemorrhoidectomy 1week and 4 days post vax. The pt was being treated with Tri-Adcortyl until the day of surgery. The vaccinee was hospitalized for 1 day. The procedure was performed under anesthesia and the pt was prescribed unspecified pain killers for post operative pain relief. In addition he was given Lactulose and Fybogel. The event is now considered to be resolved. The investigator considered the event to be moderate and unrelated to study medication. The Medical Reviewer also considered the event to be unrelated.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and demographics. Current conditions and medical history was not reported. On 26-SEP-2014, the patient was vaccinated with M-M-R II, lot number: H 017436, expiry date- 20_SEP-2014, 0.5 milliliter, subcutaneous for unknown indication. Concomitant medications were not reported. On 26-SEP-2014, expired dose of M-M-R II was inadvertently administered. No adverse effects reported. Product quality complaint was not reported. Additional information has been requested.
arm soreness at injection site; vaccine was brownish in color; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm soreness at injection site) and PRODUCT COLOUR ISSUE (vaccine was brownish in color) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced VACCINATION SITE PAIN (arm soreness at injection site) and PRODUCT COLOUR ISSUE (vaccine was brownish in color). At the time of the report, VACCINATION SITE PAIN (arm soreness at injection site) and PRODUCT COLOUR ISSUE (vaccine was brownish in color) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details provided  No treatment details provided   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow up information received on 10-MAY-2021,Contact information updated
Her husband has a rash that runs down his leg and while doing research she saw there was a concern that it could be COVID-19 Vaccine related regarding a previous COVID-19 Vaccine he received.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 77-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: moderna covid-19 vaccine (DOSE 1, SINGLE), administration date: 06Feb2021, when the patient was 74-year-old, for COVID-19 immunization; moderna covid-19 vaccine (DOSE 2, SINGLE), administration date: 06Mar2021, when the patient was 74-year-old, for COVID-19 immunization; moderna covid-19 vaccine (DOSE 3 (BOOSTER), SINGLE), administration date: 27Oct2021, when the patient was 75-year-old, for COVID-19 immunization; moderna covid-19 vaccine (DOSE 4 (BOOSTER), SINGLE), administration date: 12Apr2022, when the patient was 75-year-old, for COVID-19 immunization. The following information was reported: RASH (non-serious), outcome "unknown", described as "Her husband has a rash that runs down his leg and while doing research she saw there was a concern that it could be COVID-19 Vaccine related regarding a previous COVID-19 Vaccine he received.".  Additional information: Her husband has a rash that runs down his leg and while doing research she saw there was a concern that it could be COVID- 19 Vaccine related regarding a previous COVID-19 Vaccine he received. Rash is on her husband's right leg. Previous COVID-19 Vaccines: Caller states her and her husband had a combination of Moderna and Pfizer. Her husband has had quite a few COVID-19 Vaccines. Moderna COVID-19 Vaccine dates: 06Feb2021 06Mar2021 27Oct2021 12Apr2022. The Moderna vaccines are the only ones listed on his vaccine card. He has had Pfizer COVID-19 Vaccines after 12Apr2022, but they are not listed on the card. They stopped putting them on the vaccine card.   The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 11Feb2021 14:30 (Lot number: EN6201) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (first dose lot number is EK9231., Time: 09:45 AM,, Anatomical site of injection: Shoulder,, Route of Administration: Intramuscular.), administration date: 22Jan2021, for COVID-19 immunization, reaction(s): "Sore upper arm". The following information was reported: CHILLS (non-serious) with onset Feb2021, outcome "unknown", described as "chills".  Follow-up attempts are completed. No further information is expected.
pt had a positive COVID test from Healthcare Drive Thru Testing Center on 8/30/21; pt died at home; no other medical records
Intermittent blurred vision, edema,  Rt sided chest pain, and fatigue.
Janssen COVID-19 Vaccine EUA. I had the vaccine at around 4:00 pm and felt fine until I woke up around 12:30 am. I had severe chills and shakes, body aches, and a headache. It eventually turned into sweating. Around 8:30am, it's not as severe. I took tylenol around 8:30 am and do not feel like I have the chills anymore, just body aches and some fatigue.
I had a fast beating heart felt like anxiety as my pulse read regular on my watch. My right side of my face around the cheek, eye, and ear area began to tingle and feel numb around 20 to 30 min. After the shot was administered. It was only on the side of my face that Moderna covid vaccine was given. It ended up going away after 4 hours or so. The next day I had normal reactions to the shot for someone that had covid such as low fever, muscle inflammation, aches, and this brain fog, chills in my sleep.
Pain at injection site 5 hours after shot Fever, weakness, chills, irritability 10 hours after shot Intense heartburn, nausea 22 hours after shot